{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:53:20Z","timestamp":1777949600652,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02028-7","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:04:45Z","timestamp":1774436685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics and clinical analysis of CETN2\u2019s impact on platinum resistance and prognosis in epithelial ovarian cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Lin-yuan","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"2028_CR1","doi-asserted-by":"publisher","first-page":"1161489","DOI":"10.3389\/fonc.2023.1161489","volume":"13","author":"Z Chen","year":"2023","unstructured":"Chen Z, Xing J, Zheng C, Zhu Q, He P, Zhou D, Li X, Li Y, Qi S, Ouyang Q, Zhang B, Xie Y, Ren J, Cao B, Zhu S, Huang J. Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection. Front Oncol. 2023;13:1161489. https:\/\/doi.org\/10.3389\/fonc.2023.1161489. PMID: 37251926; PMCID: PMC10213680.","journal-title":"Front Oncol"},{"key":"2028_CR2","doi-asserted-by":"publisher","first-page":"733164","DOI":"10.3389\/fgene.2022.733164","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Xu C, Sun H. DNA damage Repair-Related genes signature for immune infiltration and outcome in cervical cancer. Front Genet. 2022;13:733164. https:\/\/doi.org\/10.3389\/fgene.2022.733164. PMID: 35309134; PMCID: PMC8927729.","journal-title":"Front Genet"},{"key":"2028_CR3","doi-asserted-by":"publisher","first-page":"1965451","DOI":"10.1155\/2022\/1965451","volume":"2022","author":"T Wang","year":"2022","unstructured":"Wang T, Liu D, Wang L, Liu M, Duan W, Yi J, Yi Y. DNA repair genes are associated with subtype Classification, Prognosis, and immune infiltration in uveal melanoma. J Oncol. 2022;2022:1965451. https:\/\/doi.org\/10.1155\/2022\/1965451. PMID: 35096056; PMCID: PMC8791741.","journal-title":"J Oncol"},{"issue":"4","key":"2028_CR4","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/cancers14040865","volume":"14","author":"JA Son","year":"2022","unstructured":"Son JA, Ahn HR, You D, Baek GO, Yoon MG, Yoon JH, Cho HJ, Kim SS, Nam SW, Eun JW, Cheong JY. Novel gene signatures as prognostic biomarkers for predicting the recurrence of hepatocellular carcinoma. Cancers (Basel). 2022;14(4):865. https:\/\/doi.org\/10.3390\/cancers14040865. PMID: 35205612; PMCID: PMC8870597.","journal-title":"Cancers (Basel)"},{"key":"2028_CR5","doi-asserted-by":"publisher","first-page":"858347","DOI":"10.3389\/fncel.2022.858347","volume":"16","author":"E Degl\u2019Innocenti","year":"2022","unstructured":"Degl\u2019Innocenti E, Poloni TE, Medici V, Recupero L, Dell\u2019Amico C, Vannini E, Borello U, Mazzanti CM, Onorati M, Dell\u2019Anno MT. Centrin 2: A novel marker of mature and neoplastic human astrocytes. Front Cell Neurosci. 2022;16:858347. PMID: 35573835; PMCID: PMC9100563.","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"2028_CR6","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/1078-0432.CCR-20-3913","volume":"27","author":"DF Boreel","year":"2021","unstructured":"Boreel DF, Span PN, Heskamp S, Adema GJ, Bussink J. Targeting oxidative phosphorylation to increase the efficacy of Radio- and Immune-Combination therapy. Clin Cancer Res. 2021;27(11):2970\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3913. Epub 2021 Jan 8. PMID: 33419779.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2028_CR7","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1038\/s41467-020-17127-2","volume":"11","author":"H Kim","year":"2020","unstructured":"Kim H, Xu H, George E, Hallberg D, Kumar S, Jagannathan V, Medvedev S, Kinose Y, Devins K, Verma P, Ly K, Wang Y, Greenberg RA, Schwartz L, Johnson N, Scharpf RB, Mills GB, Zhang R, Velculescu VE, Brown EJ, Simpkins F. Combining PARP with ATR Inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models. Nat Commun. 2020;11(1):3726. https:\/\/doi.org\/10.1038\/s41467-020-17127-2. PMID: 32709856; PMCID: PMC7381609.","journal-title":"Nat Commun"},{"issue":"3","key":"2028_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/medicina59030544","volume":"59","author":"A Havasi","year":"2023","unstructured":"Havasi A, Cainap SS, Havasi AT, Cainap C. Ovarian Cancer-Insights into platinum resistance and overcoming it. Med (Kaunas). 2023;59(3):544. https:\/\/doi.org\/10.3390\/medicina59030544. PMID: 36984544; PMCID: PMC10057458.","journal-title":"Med (Kaunas)"},{"issue":"7959","key":"2028_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41586-023-05959-z","volume":"617","author":"J Kim","year":"2023","unstructured":"Kim J, Li CL, Chen X, Cui Y, Golebiowski FM, Wang H, Hanaoka F, Sugasawa K, Yang W. Lesion recognition by XPC, TFIIH and XPA in DNA excision repair. Nature. 2023;617(7959):170\u20135. https:\/\/doi.org\/10.1038\/s41586-023-05959-z. Epub 2023 Apr 19. PMID: 37076618; PMCID: PMC10416759.","journal-title":"Nature"},{"key":"2028_CR10","doi-asserted-by":"publisher","unstructured":"Tang H, Zi H, Zhou D, Li Y, Li X, Chen Z, Zhu Q, Ouyang Q, He P, Chen S, Li Y, Long J, Huang J. Role of the nucleotide excision repair function of CETN2 in the Inhibition of the sensitivity of hepatocellular carcinoma cells to oxaliplatin. Carcinog 2025 Feb 13:bgaf003. https:\/\/doi.org\/10.1093\/carcin\/bgaf003. Epub ahead of print. PMID: 39945187.","DOI":"10.1093\/carcin\/bgaf003"},{"issue":"21","key":"2028_CR11","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/hmg\/ddab171","volume":"30","author":"J Zhang","year":"2021","unstructured":"Zhang J, He X, Wu H, Zhang X, Yang S, Liu C, Liu S, Hua R, Zhou S, Zhao S, Hu F, Zhang J, Liu W, Cheng H, Gao Y, Zhang F, Cao Y, Liu M. Loss of DRC1 function leads to multiple morphological abnormalities of the sperm flagella and male infertility in human and mouse. Hum Mol Genet. 2021;30(21):1996\u20132011. https:\/\/doi.org\/10.1093\/hmg\/ddab171. PMID: 34169321; PMCID: PMC8522639.","journal-title":"Hum Mol Genet"},{"key":"2028_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12935-020-1113-6","volume":"20","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Lin E, Zhuang H, Xie L, Feng X, Liu J, Yu Y. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma. Cancer Cell Int. 2020;20:27. https:\/\/doi.org\/10.1186\/s12935-020-1113-6. PMID: 32002016; PMCID: PMC6986036.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"2028_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/path.5511","volume":"252","author":"DR Cochrane","year":"2020","unstructured":"Cochrane DR, Campbell KR, Greening K, Ho GC, Hopkins J, Bui M, Douglas JM, Sharlandjieva V, Munzur AD, Lai D, DeGrood M, Gibbard EW, Leung S, Boyd N, Cheng AS, Chow C, Lim JL, Farnell DA, Kommoss S, Kommoss F, Roth A, Hoang L, McAlpine JN, Shah SP, Huntsman DG. Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours. J Pathol. 2020;252(2):201\u201314. https:\/\/doi.org\/10.1002\/path.5511. Epub 2020 Aug 22. PMID: 32686114.","journal-title":"J Pathol"},{"issue":"1","key":"2028_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/s12885-020-07125-4","volume":"20","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Wang Q, Xia Y, Xiong X, Weng S, Ni H, Ye Y, Chen L, Lin J, Chen Y, Niu H, Chen X, Lin Y. Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes. BMC Cancer. 2020;20(1):644. https:\/\/doi.org\/10.1186\/s12885-020-07125-4. PMID: 32650755; PMCID: PMC7350204.","journal-title":"BMC Cancer"},{"issue":"2","key":"2028_CR15","doi-asserted-by":"publisher","first-page":"zcab022","DOI":"10.1093\/narcan\/zcab022","volume":"3","author":"AP Wiegmans","year":"2021","unstructured":"Wiegmans AP, Ward A, Ivanova E, Duijf PHG, Adams MN, Najib IM, Van Oosterhout R, Sadowski MC, Kelly G, Morrical SW, O\u2019Byrne K, Lee JS, Richard DJ. Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer. NAR Cancer. 2021;3(2):zcab022. https:\/\/doi.org\/10.1093\/narcan\/zcab022. PMID: 34316709; PMCID: PMC8210242.","journal-title":"NAR Cancer"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02028-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:50:38Z","timestamp":1777863038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02028-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2028"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02028-7","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}